NCT00472004View on ClinicalTrials.gov

Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women

PHASE4CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Vasomotor Symptoms
Interventions
DRUG

17B Estradiol (1mg) / (0.125 mg) TMG Continuous combined (Totelle)

17B Estradiol (1mg) / (0.125 mg) TMG Continuous combined, 1 Daily, 1 year duration

DRUG

Tibolone (Livial)

Tibolone 2.5 mg 1 daily, 1 year duration

Trial Locations (1)

01090

Pfizer Investigational Site, Monterrey

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00472004 - Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women | Biotech Hunter | Biotech Hunter